An overview: extent of teratogenicity of common medications in fetal development

An overview: extent of teratogenicity of common medications in fetal development

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Bibliografiset tiedot
Päätekijä: Islam, Humayra
Muut tekijät: Akter, Raushanara
Aineistotyyppi: Opinnäyte
Kieli:English
Julkaistu: Brac University 2022
Aiheet:
Fetal development
FDA classification
Common drugs in gestation
Teratogenicity
Placenta
Fetal BBB
Fetus > Growth.
Fetus > Development.
Linkit:http://hdl.handle.net/10361/16602

Internet

http://hdl.handle.net/10361/16602

Samankaltaisia teoksia